Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's Disease (AD) is a progressive neurological disorder that can result in significant cog...
Unsupervised anomaly detection in brain imaging is challenging. In this paper, we propose self-sup...
Multimodal neuroimaging is an emerging field that leverages multiple sources of information to diagn...
Early diagnosis and discovery of therapeutic drug targets are crucial objectives for the effective...
The increasing proportion of the older adult population has made the smart home care industry one ...
Augmenting traditional genome-wide association studies (GWAS) with advanced machine learning algorit...
Recent advances in single-cell RNA-Sequencing (scRNA-Seq) technologies have revolutionized our abili...
The interactions between long noncoding RNA (lncRNA) and microRNA (miRNA) play critical roles in lif...
Alzheimer's disease (AD) is characterized by progressive neurodegeneration and results in detrimen...
Nanorobots are a promising development in targeted drug delivery and the treatment of neurological...
Neuropathologic changes of Alzheimer disease (AD) including Aβ accumulation and neuroinflammation ar...
Cognitive decline in Parkinson's disease (PD) varies widely. While models to predict cognitive progr...
Understanding the relationship between cognition and intrinsic brain activity through purely data-...
Clinical decision-making relies heavily on causal reasoning and longitudinal analysis. For example...
Mild Cognitive Impairment (MCI) is an early stage of Alzheimer's disease (AD), a form of neurodege...
Different brain imaging modalities offer unique insights into brain function and structure. Combin...
Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the leading cause of dementia...
We employ the Hopfield model as a simplified framework to explore both the memory deficits and the...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory and c...
SUMMARY: The vast generation of genetic data poses a significant challenge in efficiently uncovering...
Cerebral microbleeds, markers of brain damage from vascular and amyloid pathologies, are linked to...